{"DataElement":{"publicId":"6568706","version":"1","preferredName":"Dinutuximab Reason Treatment Not Administered Category","preferredDefinition":"The indicated reason for which Dinutuximab (Ch14.18) was not administered.","longName":"CH1418_ADMR_RPD_IRSN","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6568680","version":"1","preferredName":"Dinutuximab Reason Treatment Not Administered","preferredDefinition":"A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Dinutuximab binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung._The reason the treatment was not administered.","longName":"3061305v1.0:6568678v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"3061305","version":"1","preferredName":"Monoclonal Antibody Ch14.18","preferredDefinition":"A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Monoclonal antibody Ch14.18 binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung. (NCI04)","longName":"C1570","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dinutuximab","conceptCode":"C1570","definition":"A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Dinutuximab binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"844F7470-A917-6DDD-E040-BB89AD4303F0","latestVersionIndicator":"Yes","beginDate":"2010-04-15","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-04-15","modifiedBy":"ONEDATA","dateModified":"2010-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6568678","version":"1","preferredName":"Reason Treatment Not Administered","preferredDefinition":"The reason the treatment was not administered.","longName":"C102704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason Treatment Not Administered","conceptCode":"C102704","definition":"The reason the treatment was not administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97D80A-3C99-2027-E053-F662850A0B70","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B97D80A-3CAA-2027-E053-F662850A0B70","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"MAESKEB","dateModified":"2018-11-30","changeDescription":"Curated for ANBL17P1","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6568703","version":"1","preferredName":"Reason Treatment Not Administered Category","preferredDefinition":"The reason the treatment was not administered._A grouping of items based on some commonality or by user defined characteristics.","longName":"6568703v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B9AAF6F-8CE7-2386-E053-F662850AD580","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"},{"value":"New requirement for supplemental oxygen","valueDescription":"New requirement for supplemental oxygen","ValueMeaning":{"publicId":"6568704","version":"1","preferredName":"New requirement for supplemental oxygen","longName":"6568704","preferredDefinition":"New requirement for supplemental oxygen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B9AAF6F-8CF1-2386-E053-F662850AD580","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B9AAF6F-8D0A-2386-E053-F662850AD580","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"},{"value":"Adequate stem cells were not collected","valueDescription":"Adequate stem cells were not collected","ValueMeaning":{"publicId":"6568705","version":"1","preferredName":"Adequate stem cells were not collected","longName":"6568705","preferredDefinition":"Adequate stem cells were not collected","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B9AAF6F-8D14-2386-E053-F662850AD580","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B9AAF6F-8D2D-2386-E053-F662850AD580","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6568702","version":"1","preferredName":"Reason Treatment Not Administered Category","preferredDefinition":"The reason the treatment was not administered.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C102704:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason Treatment Not Administered","conceptCode":"C102704","definition":"The reason the treatment was not administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B9AAF6F-8CC1-2386-E053-F662850AD580","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"ONEDATA","dateModified":"2018-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B9AAF6F-8CD2-2386-E053-F662850AD580","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"COBARRUBIAK","dateModified":"2018-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If No, reason(s) Dinutuximab","type":"Preferred Question Text","description":"If No, reason(s) Dinutuximab was not administered during this reporting period:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B9ABC25-86E4-1D94-E053-F662850A8E9C","latestVersionIndicator":"Yes","beginDate":"2018-11-26","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-26","modifiedBy":"COBARRUBIAK","dateModified":"2018-11-30","changeDescription":"Curated for ANBL17P1","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}